Bruker Corp (BRKR)
54.51
-1.44
(-2.57%)
USD |
NASDAQ |
Nov 14, 16:00
54.51
0.00 (0.00%)
After-Hours: 20:00
Bruker Research and Development Expense (Quarterly): 98.10M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 98.10M |
| June 30, 2024 | 92.20M |
| March 31, 2024 | 81.80M |
| December 31, 2023 | 83.50M |
| September 30, 2023 | 71.30M |
| June 30, 2023 | 71.00M |
| March 31, 2023 | 69.00M |
| December 31, 2022 | 63.50M |
| September 30, 2022 | 56.20M |
| June 30, 2022 | 59.60M |
| March 31, 2022 | 56.60M |
| December 31, 2021 | 58.10M |
| September 30, 2021 | 52.10M |
| June 30, 2021 | 55.80M |
| March 31, 2021 | 54.80M |
| December 31, 2020 | 57.10M |
| September 30, 2020 | 48.30M |
| June 30, 2020 | 44.10M |
| March 31, 2020 | 48.50M |
| December 31, 2019 | 46.70M |
| September 30, 2019 | 46.10M |
| June 30, 2019 | 48.50M |
| March 31, 2019 | 46.40M |
| December 31, 2018 | 44.80M |
| September 30, 2018 | 41.80M |
| Date | Value |
|---|---|
| June 30, 2018 | 43.60M |
| March 31, 2018 | 43.20M |
| December 31, 2017 | 43.10M |
| September 30, 2017 | 40.60M |
| June 30, 2017 | 40.30M |
| March 31, 2017 | 37.60M |
| December 31, 2016 | 37.10M |
| September 30, 2016 | 37.90M |
| June 30, 2016 | 36.80M |
| March 31, 2016 | 36.10M |
| December 31, 2015 | 36.70M |
| September 30, 2015 | 34.30M |
| June 30, 2015 | 37.50M |
| March 31, 2015 | 37.20M |
| December 31, 2014 | 41.60M |
| September 30, 2014 | 42.10M |
| June 30, 2014 | 44.50M |
| March 31, 2014 | 46.00M |
| December 31, 2013 | 49.10M |
| September 30, 2013 | 45.50M |
| June 30, 2013 | 46.50M |
| March 31, 2013 | 49.40M |
| December 31, 2012 | 50.30M |
| September 30, 2012 | 44.90M |
| June 30, 2012 | 51.90M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
44.10M
Minimum
Jun 2020
98.10M
Maximum
Sep 2024
63.42M
Average
57.60M
Median
Research and Development Expense (Quarterly) Benchmarks
| Azenta Inc | 7.913M |
| Harvard Bioscience Inc | 2.567M |
| Bionano Genomics Inc | 6.831M |
| Akoya Biosciences Inc | 5.288M |
| Singular Genomics Systems Inc | 10.73M |